Smith, M R <br/><br/>
Complementary and alternative therapies for advanced prostate cancer.  [electronic resource] 

 -  Hematology/oncology clinics of North America  Jun 2001 
 - 559-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0889-8588 
<br/><br/><label>Standard No.: </label>10.1016/s0889-8588(05)70232-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acupuncture<br/>Adenocarcinoma--drug therapy<br/>Androgen Antagonists--therapeutic use<br/>Androgens<br/>Anemia--chemically induced<br/>Anticarcinogenic Agents--therapeutic use<br/>Antineoplastic Agents--adverse effects<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Complementary Therapies<br/>Depression--chemically induced<br/>Diphosphonates--therapeutic use<br/>Drugs, Chinese Herbal--therapeutic use<br/>Erythropoietin--therapeutic use<br/>Female<br/>Flushing--chemically induced<br/>Humans<br/>Hypericum<br/>Male<br/>Multicenter Studies as Topic<br/>Neoplasms, Hormone-Dependent--drug therapy<br/>Osteoporosis--chemically induced<br/>Phytotherapy<br/>Pilot Projects<br/>Plant Extracts--therapeutic use<br/>Prospective Studies<br/>Prostatic Hyperplasia--drug therapy<br/>Prostatic Neoplasms--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Serenoa